oxonic acid has been researched along with Angiogenesis, Pathologic in 9 studies
Oxonic Acid: Antagonist of urate oxidase.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The prognosis for hepatocellular carcinoma with extrahepatic metastasis or vascular invasion is very poor." | 2.47 | [A successful case of systemic chemotherapy followed by liver resection for advanced hepatocellular carcinoma with highly vascular invasion and multiple pulmonary metastases]. ( Kakisaka, T; Kamachi, H; Kamiyama, T; Matsushita, M; Mizukami, T; Nakanishi, K; Tahara, M; Taniguchi, M; Todo, S; Yokoo, H, 2011) |
| " Recently, we showed that the combination of oral metronomic S-1 dosing with oxaliplatin (l-OHP)-containing PEG-coated "neutral" liposomes exerted excellent antitumor activity." | 1.38 | Combination therapy with metronomic S-1 dosing and oxaliplatin-containing PEG-coated cationic liposomes in a murine colorectal tumor model: synergy or antagonism? ( Abu Lila, AS; Doi, Y; Ichihara, M; Ishida, T; Kiwada, H; Okada, T, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ferdous, T | 1 |
| Harada, K | 2 |
| Kin, T | 1 |
| Harada, T | 1 |
| Ueyama, Y | 1 |
| Tsuji, W | 1 |
| Ishiguro, H | 1 |
| Tanaka, S | 1 |
| Takeuchi, M | 1 |
| Ueno, T | 1 |
| Toi, M | 1 |
| Chen, FG | 1 |
| Wang, JJ | 1 |
| Xue, Q | 1 |
| Mizukami, T | 1 |
| Kamiyama, T | 1 |
| Nakanishi, K | 1 |
| Taniguchi, M | 1 |
| Yokoo, H | 1 |
| Tahara, M | 1 |
| Kakisaka, T | 1 |
| Kamachi, H | 1 |
| Matsushita, M | 1 |
| Todo, S | 1 |
| Higuchi, M | 1 |
| Suzuki, H | 1 |
| Shio, Y | 1 |
| Satoh, Y | 1 |
| Kitamura, M | 1 |
| Gotoh, M | 1 |
| Abu Lila, AS | 1 |
| Okada, T | 1 |
| Doi, Y | 1 |
| Ichihara, M | 1 |
| Ishida, T | 1 |
| Kiwada, H | 1 |
| Masaki, T | 1 |
| Ohkawa, S | 1 |
| Amano, A | 1 |
| Ueno, M | 1 |
| Miyakawa, K | 1 |
| Tarao, K | 1 |
| Kawashima, Y | 1 |
| Yoshida, H | 1 |
| Sato, M | 1 |
| Nishimura, G | 1 |
| Yanoma, S | 1 |
| Satake, K | 1 |
| Ikeda, Y | 1 |
| Taguchi, T | 1 |
| Nakamura, Y | 1 |
| Hirose, F | 1 |
| Tsukuda, M | 1 |
1 review available for oxonic acid and Angiogenesis, Pathologic
| Article | Year |
|---|---|
[A successful case of systemic chemotherapy followed by liver resection for advanced hepatocellular carcinoma with highly vascular invasion and multiple pulmonary metastases].
Topics: Antimetabolites, Antineoplastic; Carcinoma, Hepatocellular; Combined Modality Therapy; Drug Combinat | 2011 |
1 trial available for oxonic acid and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Orally administered S-1 suppresses circulating endothelial cell counts in metastatic breast cancer patients.
Topics: 4-Butyrolactone; Administration, Oral; Adult; Aged; Antigens, CD34; Antimetabolites, Antineoplastic; | 2014 |
7 other studies available for oxonic acid and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Efficacy of schedule-dependent metronomic S-1 chemotherapy in human oral squamous cell carcinoma cells.
Topics: Administration, Metronomic; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Carc | 2013 |
[Inhibition of angiogenesis of LCI-D20 hepatocellular carcinoma by metronomic chemotherapy of S-1].
Topics: Animals; Antimetabolites, Antineoplastic; Apoptosis; Carcinoma, Hepatocellular; Drug Combinations; F | 2009 |
[A case of long-term survival after resection of aortic arch for locally advanced non-small cell lung cancer with induction chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Aorta, Thoracic; Carcinoma, Non-Small-Cell Lung; Cis | 2011 |
Combination therapy with metronomic S-1 dosing and oxaliplatin-containing PEG-coated cationic liposomes in a murine colorectal tumor model: synergy or antagonism?
Topics: Administration, Metronomic; Angiogenesis Inhibitors; Animals; Antineoplastic Combined Chemotherapy P | 2012 |
Noninvasive assessment of tumor vascularity by contrast-enhanced ultrasonography and the prognosis of patients with nonresectable pancreatic carcinoma.
Topics: Adult; Aged; Contrast Media; Deoxycytidine; Disease-Free Survival; Drug Combinations; Female; Gemcit | 2005 |
S-1 inhibits tumorigenicity and angiogenesis of human oral squamous cell carcinoma cells by suppressing expression of phosphorylated Akt, vascular endothelial growth factor and fibroblast growth factor-2.
Topics: Animals; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Cell Line, Tumor; Drug Combinati | 2007 |
An experimental model of tumor dormancy therapy for advanced head and neck carcinoma.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Antioxidan | 2000 |